aceComprehensive analysis and external validation of a glycolysis-related gene signature as a prognostic index for skin cutaneous melanoma
Skin cutaneous melanoma (SKCM) is the third most common cause of cancer-related deaths globally. Today, precise biomarkers to predict melanoma prognosis are quite limited. Aerobic glycolysis serves as the primary metabolic pathway for malignancies to meet their rapid growth demands. This study built a glycolysis-associated gene (GAG) signature to evaluate prognosis and immunotherapy response of SKCM. Data acquired from the Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) databases were evalua…
A four-gene glycolysis risk model built with machine learning effectively forecasted survival and treatment efficacy for skin cutaneous melanoma patients.
Evidence
- Peer-reviewedMelanoma Research2026-10-06
How should this claim be treated?
Truvace Impact Record TRV-2026-1322, v1: “Comprehensive analysis and external validation of a glycolysis-related gene signature as a prognostic index for skin cutaneous melanoma.” Truvace, 2026-10-11. /record/TRV-2026-1322 (accessed at citation time). sha256 5306d1fcb25b89cb…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1322 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.